Patni Rajiv

Patni Rajiv is listed in filings as Director at BioXcel Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 12, 2026, including 3 public disclosures. Recent filings connect the profile to BioXcel Therapeutics, Inc. (BTAI) and Quince Therapeutics, Inc. (QNCX). The current snapshot covers public activity from Jan 16, 2025 to Jan 12, 2026. Reported amounts are shown as $34.2K to $15.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.